Xanthohumol microbiome and signature in adults with Crohn’s disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial

被引：0
作者：
Blake O. Langley
Jennifer Joan Ryan
John Phipps
Lita Buttolph
Brenna Bray
Joseph E. Aslan
Thomas O. Metz
Jan F. Stevens
Ryan Bradley
机构：
[1] Helfgott Research Institute,School of Nursing
[2] National University of Natural Medicine (NUNM),School of Medicine
[3] University of Washington,Biological Sciences Division
[4] Oregon Health and Science University,College of Pharmacy and the Linus Pauling Institute
[5] Pacific Northwest National Laboratory,Herbert Wertheim School of Public Health and Human Longevity Science
[6] Oregon State University,undefined
[7] University of California,undefined
[8] San Diego,undefined
来源：
Trials | / 23卷
关键词：
Natural product; Xanthohumol; Crohn’s disease; Inflammatory bowel disease; Microbiome; Inflammation; Safety; Tolerability; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial
    Pai, Nikhil
    Popov, Jelena
    Hill, Lee
    Hartung, Emily
    BMJ OPEN, 2019, 9 (11):
  • [22] Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn's Disease: a Pilot Randomized Placebo-Controlled Trial
    Mikocka-Walus, Antonina
    Hughes, Patrick A.
    Bampton, Peter
    Gordon, Andrea
    Campaniello, Melissa A.
    Mavrangelos, Chris
    Stewart, Benjamin J.
    Esterman, Adrian
    Andrews, Jane M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04) : 509 - 514
  • [23] Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn's Disease: A Randomized Placebo-Controlled Trial
    Smith, Jill P.
    Bingaman, Sandra I.
    Ruggiero, Francesca
    Mauger, David T.
    Mukherjee, Aparna
    McGovern, Christopher O.
    Zagon, Ian S.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (07) : 2088 - 2097
  • [24] Efficacy and Safety of Useul for Dry Eye Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel, Phase 2 Clinical Trial
    Lyu, Yee-Ran
    Kwon, O-Jin
    Park, Bongkyun
    Jung, Hyun-A
    Lee, Ga-Young
    Kim, Chan-Sik
    HEALTHCARE, 2024, 12 (23)
  • [25] Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol
    Gu, Bonita
    De Gregorio, Michael
    Pipicella, Joseph Louis
    Vande Casteele, Niels
    Andrews, Jane M.
    Begun, Jakob
    Connell, William
    D'Souza, Basil
    Gholamrezaei, Ali
    Hart, Ailsa
    Liew, Danny
    Radford-Smith, Graham
    Rimola, Jordi
    Sutherland, Tom
    Toong, Catherine
    Woods, Rodney
    Wu, Yang
    Xuan, Wei
    Williams, Astrid-Jane
    Ng, Watson
    Ding, Nik Sheng
    Connor, Susan
    BMJ OPEN, 2021, 11 (07):
  • [26] Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease
    Schrag, A.
    Carroll, C.
    Duncan, G.
    Molloy, S.
    Grover, L.
    Hunter, R.
    Brown, R.
    Freemantle, N.
    Whipps, J.
    Serfaty, M. A.
    Lewis, G.
    BMC NEUROLOGY, 2022, 22 (01)
  • [27] The effects of AG1® supplementation on the gut microbiome of healthy adults: a randomized, double-blind, placebo-controlled clinical trial
    La Monica, Michael B.
    Raub, Betsy
    Hartshorn, Shelley
    Gustat, Ashley L.
    Grdic, Jodi
    Kirby, Trevor O.
    Townsend, Jeremy R.
    Sandrock, Jen
    Ziegenfuss, Tim N.
    JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, 2024, 21 (01)
  • [28] Comparison of Two Dosing Methods for Induction of Response and Remission with Oral Budesonide in Active Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial
    Levine, Arie
    Kori, Michal
    Dinari, Gabriel
    Broide, Efrat
    Shaoul, Ron
    Yerushalmi, Baruch
    On, Avi
    Bujanover, Yoram
    Proels, Markus
    Greinwald, Roland
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (07) : 1055 - 1061
  • [29] Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
    Tobback, Els
    Degroote, Sophie
    Buysse, Sabine
    Delesie, Liesbeth
    Van Dooren, Lucas
    Vanherrewege, Sophie
    Barbezange, Cyril
    Hutse, Veronik
    Romano, Marta
    Thomas, Isabelle
    Padalko, Elizaveta
    Callens, Steven
    De Scheerder, Marie-Angelique
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 628 - 635
  • [30] Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial
    Tamtaji, Omid Reza
    Taghizadeh, Mohsen
    Kakhaki, Reza Daneshvar
    Kouchaki, Ebrahim
    Bahmani, Fereshteh
    Borzabadi, Shokoofeh
    Oryan, Shahrbanoo
    Mafi, Alireza
    Asemi, Zatollah
    CLINICAL NUTRITION, 2019, 38 (03) : 1031 - 1035
12345